| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.22 | 8e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |